Bright light therapy in rheumatoid arthritis to improve symptoms of fatigue and other disease outcomes: a randomized controlled pilot trial.

eiden University0 个研究点目标入组 48 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

•Eligible patients are Dutch-speaking patients from the Department of Rheumatology of the Leiden University Medical Center with a physician-based diagnosis of RA and an age ≥ 18y.
•A subject must meet all of the following criteria:

•I.Treatment with glucocorticoids, melatonin, or photosensitizing medication and/or changed in type or dose within the last 3 months before start of the study.
•II.Patient's medical conditions or recent medical events potentially compromises the effects of safety of light therapy (e.g. psychosis, mania, (probable) dementia, severe drug or alcohol abuse, delirium, severe acute suicidality, history of light-induced migraine or epilepsy or severe side effects to light therapy in the past, and/or pre-existing ocular abnormalities (e.g. glaucoma, retinitis, retinopathy, and/or macular degeneration)).

发起方

eiden University